Searched for
TUBERCULOSIS DIVISION
These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...- Haryana uses AI to speed up TB elimination: Senior officialHaryana is using three Artificial Intelligence tools to combat tuberculosis. These AI solutions help detect TB cases early, monitor patient...
- Odisha, Delhi join AB-PMJAY, robust growth in digital healthcare delivery in 2025; AI next frontierIn 2025, India expanded Ayushman Bharat to Odisha and Delhi, boosting digital health with eSanjeevani's 43.2 crore tele-consultations. The ...
- Plans to restrict open market access to tuberculosis medicinesIndia is tightening access to anti-TB drugs Bedaquiline and Delamanid due to rising drug-resistant tuberculosis cases and potential misuse ...
- Kansas sees surge in tuberculosis cases, expert says ‘largest documented outbreak’ in US historyKansas is experiencing its largest tuberculosis outbreak, with 67 active cases reported across Wyandotte and Johnson counties, sparking con...
- Hyundai Motor India Foundation sets up largest oxygen generation plant at Chennai hospital"The pandemic cast a spotlight on being prepared for any eventuality. Under our global vision, Progress for Humanity, we have been supporti...
- 'Enhance testing capacity and get states to ease process of registering phlebotomists'A governmental panel dealing with Covid-19 testing and surveillance has asked the health ministry to enhance testing capacity and get state...
- FM Nirmala Sitharaman wants to eradicate TB by 2025: Know causes, symptoms & treatment of the diseaseTuberculosis is among one of the biggest risks in India, and kills 1.5 mn people every year.
- Govt employing multi-sectoral, community led approach to eliminate TB by 2025: VardhanThe Centre has also increased allocation of funds for the TB programme by four-folds, he said after releasing the 'India TB Report 2019'.
- Aadhaar or not, TB patients to get free diagnosis, medicinesNotification by Health Ministry recently made Aadhaar compulsory for TB patients and health providers but for only those seeking cash incen...
- No. of India's TB patients may be double the estimate: StudyWhile it was assumed that India's annual TB cases stands at 2.2 million a year, the study pegs this number at over 3.8 million in 2014.
- New microneedle patch for measles vaccination designedThe underside of the patch is lined with 100 solid, conical microneedles made of polymer, sugar, and vaccine that are a fraction of a milli...
- Malnutrition, not HIV, main trigger of tuberculosis in India: StudyAn annual estimated mortality of 2, 70,000 deaths means that tuberculosis claims one life in India every two minutes.
- SIT to challenge Gujarat High Court's bail to Maya Kodnani before Supreme CourtKodnani, the former Minister for Women and Child Development in the then Narendra Modi-led Gujarat government, was granted bail today.
- Former Gujarat minister Maya Kodnani gets bail in riots caseFormer Gujarat minister Maya Kodnani, sentenced to 28 years' imprisonment in the 2002 Naroda Patiya massacre case, was today granted bail b...
- A million children develop TB annually: StudyResearchers from Brigham and Women's Hospital and Harvard Medical School estimated the number of childhood tuberculosis cases at 1 million ...
- Government suffering losses by not procuring generic drugs: CAGThe CAG audit has also revealed losses to the tune of Rs 5.06 crore in Tuberculosis Division of Health Ministry.
- Ranbaxy transfers R&D unit to Daiichi SankyoRanbaxy Laboratories has transferred its research division for new drugs to Japan’s Daiichi Sankyo turning Ranbaxy into a pure generic drug...
- IIT-B gets $5 million assistanceThe Indian Institute of Technology-Bombay (IIT-B) on Wednesday received a cheque of $5 million from Romesh Wadhwani, founder of the Symphon...
- Maneesh buys Smyle for Rs 53 crIn a bid to strengthen its presence in India’s OTC pharmaceutical mkt, Mumbai-based Maneesh Pharmaceuticals has acquired Kopran’s brand Smy...
Load More
